Table 2.
Site A | Site B | Both Groups | ||||
---|---|---|---|---|---|---|
AA referral (N=5) | No AA referral (N=51) | AA referral (N=10) | No AA referral (N=24) | AA referral (N=15) | No AA referral (N=75) | |
Summary quality score | 67 | 44* | 65 | 34* | 65 | 41* |
Individual Quality Indicators | ||||||
-New memory impairment | ||||||
Assessing cognition | 100 | 64 | 57 | 11 | 67 | 48 |
Reviewing medications | 100 | 68 | 71 | 44 | 78 | 61 |
-New dementia | ||||||
Conducting neurologic exam | 100 | 67 | 50 | 0 | 60 | 50 |
Screening for depression | 100 | 100 | 100 | 50 | 100 | 88 |
Performing laboratory tests | 0 | 0 | 25 | 50 | 20 | 13 |
-Management of dementia | ||||||
Assessing functional status | 25 | 54 | 88 | 33* | 67 | 47 |
Screening for behavioral symptoms | 25 | 54 | 100 | 56* | 75 | 54 |
Discussing cholinesterase inhibitor | 100 | 62 | 50 | 89 | 64 | 70 |
Managing behavioral symptoms | 0 | 5 | 13 | 30 | 11 | 13 |
Discussing risk/benefits of anti-psychotics | 100 | NA | 100 | 67 | 100 | 67 |
Counseling about driving | 25 | 15 | 63 | 11* | 50 | 14* |
Counseling caregiver | 100 | 15* | 100 | 17* | 100 | 15* |
Specifying surrogate | 100 | 59 | 63 | 11* | 75 | 44* |
N= number of patients,
p < 0.05 comparing AA referral to No AA referral